Literature DB >> 13651742

Disturbances of pigmentation with chloroquine.

J L DALL, J A KEANE.   

Abstract

Entities:  

Keywords:  CHLOROQUINE/injurious effects; PIGMENTATION

Mesh:

Substances:

Year:  1959        PMID: 13651742      PMCID: PMC1993594          DOI: 10.1136/bmj.1.5134.1387

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  5 in total

1.  Treatment of rheumatoid arthritis with chloroquine.

Authors:  H FULD; L HORWICH
Journal:  Br Med J       Date:  1958-11-15

2.  The value of chloroquine in rheumatoid disease: a four-year study of continuous therapy.

Authors:  A W BAGNALL
Journal:  Can Med Assoc J       Date:  1957-08-01       Impact factor: 8.262

3.  The ocular complications of chloroquine therapy.

Authors:  H E HOBBS; C D CALNAN
Journal:  Lancet       Date:  1958-06-07       Impact factor: 79.321

4.  Chronic discoid lupus erythematosus: treatment with daraprim and chloroquine diphosphate (aralen).

Authors:  M J TYE; B L SCHIFF; S F COLLINS; G R BALER; B APPEL
Journal:  N Engl J Med       Date:  1954-07-08       Impact factor: 91.245

5.  Treatment of lupus erythematosus with mepacrine.

Authors:  F PAGE
Journal:  Lancet       Date:  1951-10-27       Impact factor: 79.321

  5 in total
  4 in total

1.  Current concepts in dermatology. I.

Authors:  R JACKSON
Journal:  Can Med Assoc J       Date:  1963-08-24       Impact factor: 8.262

2.  RETINOPATHY DURING CHLOROQUINE THERAPY.

Authors:  W Wilson
Journal:  Br J Ophthalmol       Date:  1961-11       Impact factor: 4.638

Review 3.  Antirheumatic drugs: clinical pharmacology and therapeutic use.

Authors:  G L Craig; W W Buchanan
Journal:  Drugs       Date:  1980-12       Impact factor: 9.546

Review 4.  Remission-inducing drugs in rheumatoid arthritis.

Authors:  T P Anastassiades
Journal:  Can Med Assoc J       Date:  1980-02-23       Impact factor: 8.262

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.